369 related articles for article (PubMed ID: 34163106)
1. COVID-19-associated diarrhea.
Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
Viruses; 2023 May; 15(6):. PubMed ID: 37376531
[TBL] [Abstract][Full Text] [Related]
3. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
6. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and gut immunomodulation.
Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
[TBL] [Abstract][Full Text] [Related]
8. Implications of SARS-CoV-2 infection for neurogastroenterology.
Marasco G; Lenti MV; Cremon C; Barbaro MR; Stanghellini V; Di Sabatino A; Barbara G
Neurogastroenterol Motil; 2021 Mar; 33(3):e14104. PubMed ID: 33591607
[TBL] [Abstract][Full Text] [Related]
9. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
Viana SD; Nunes S; Reis F
Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and diarrhea: putative mechanisms and management.
Juthi RT; Sazed SA; Sarmin M; Haque R; Alam MS
Int J Infect Dis; 2023 Jan; 126():125-131. PubMed ID: 36403817
[TBL] [Abstract][Full Text] [Related]
12. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management.
D'Amico F; Baumgart DC; Danese S; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1663-1672. PubMed ID: 32278065
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
[TBL] [Abstract][Full Text] [Related]
14. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
Grenga L; Pible O; Miotello G; Culotta K; Ruat S; Roncato MA; Gas F; Bellanger L; Claret PG; Dunyach-Remy C; Laureillard D; Sotto A; Lavigne JP; Armengaud J
Environ Microbiol; 2022 Sep; 24(9):4299-4316. PubMed ID: 35506300
[TBL] [Abstract][Full Text] [Related]
15. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2.
Guo M; Tao W; Flavell RA; Zhu S
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):269-283. PubMed ID: 33589829
[TBL] [Abstract][Full Text] [Related]
16. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
Suryana KD; Simadibrata M; Renaldi K
Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.
Zhang H; Shao B; Dang Q; Chen Z; Zhou Q; Luo H; Yuan W; Sun Z
Front Immunol; 2021; 12():674074. PubMed ID: 34858386
[TBL] [Abstract][Full Text] [Related]
19. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
